2. Signaling Pathways
  3. Others
  4. Drug Derivative

Drug Derivative

Drug derivative

Drug derivatives are derived from parent compounds. They replace or add atoms and groups through chemical reactions to optimize the various properties of the parent compound and reduce side effects. The application of drug derivatives provides a diverse compound library for drug research and development and accelerates the discovery of new drugs. For example, urea derivatives Glibenclamide can prolong the blood sugar-lowering effect of anti-diabetic drugs.

Drug Derivative Related Products (1342):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-130201
    Deacetylsaptomycin D
    Deacetylsaptomycin D is a deacetylated saptomycin with in vitro antitumor activity. Deacetylsaptomycin D inhibits the growth of mouse methoxy-A fibrosarcoma cells.
    Deacetylsaptomycin D
  • HY-135479
    A28695B
    A28695B is an active compound.
    A28695B
  • HY-122250
    LY 288601
    LY 288601 is a potent anticancer agent.
    LY 288601
  • HY-171044
    Anticancer agent 261
    Anticancer agent 261 (compound 13) is an anticancer compound.
    Anticancer agent 261
  • HY-111301
    FR217840
    FR217840 is an active compound.
    FR217840
  • HY-N4204
    Daidzein diacetate
    Daidzein diacetate is a derivative of Daidzein that is a soy isoflavone.
    Daidzein diacetate
  • HY-124245
    3-Hydroxy desloratadine
    3-Hydroxy desloratidine is a metabolite of Desloratidine.
    3-Hydroxy desloratadine
  • HY-116167
    RY 024
    RY 024 is an active compound.
    RY 024
  • HY-137933
    5,6,7-Trimethoxycoumarin
    5,6,7-Trimethoxycoumarin is a coumarin that can be isolated from Artemisia apiacea.
    5,6,7-Trimethoxycoumarin
  • HY-18005
    4-Aza-Oleanolic acid methyl ester
    4-Aza-Oleanolic acid methyl ester is a triterpenic derivative.
    4-Aza-Oleanolic acid methyl ester
  • HY-W659059
    N-Methyl-1-phenylpropan-1-amine hydrochloride
    N-Methyl-1-phenylpropan-1-amine hydrochloride is structurally categorized as a benzylamine.
    N-Methyl-1-phenylpropan-1-amine hydrochloride
  • HY-101657
    Clocoumarol
    Clocoumarol is an active compound.
    Clocoumarol
  • HY-136997
    M-5MPEP
    M-5MPEP is an active compound.
    M-5MPEP
  • HY-105270A
    Tallimustine hydrochloride
    Tallimustine hydrochloride, a distamycin-A derivative, is an anticancer agent.
    Tallimustine hydrochloride
  • HY-113594
    ICI 200355
    ICI 200355 is an active compound.
    ICI 200355
  • HY-116487
    R-18893
    R-18893 is an active compound.
    R-18893
  • HY-133623
    1,1,1-Tribromoacetone
    1,1,1-Tribromoacetone is a tribromide product based on bromoacetone.
    1,1,1-Tribromoacetone
  • HY-N6898
    3-O-Acetylbufotalin
    3-O-Acetylbufotalin is a derivate of bufadienolide, with anti-cancer activity.
    3-O-Acetylbufotalin
  • HY-117618
    KF-14124
    KF-14124, an orally active organic nitrate, a long-acting vasodilator with highly selective venous dilating action. KF-14124 is used in the study for angina pectoris. KF-14124 shows good oral inhibition of lysine-vasopressin induced coronary vasospasm with a potency.
    KF-14124
  • HY-W269511
    NW-1689
    NW-1689 is a process-related impurity of safinamide mesilate (SAFM). SAFM is a drug used to treat Parkinson's disease (PD). It is a highly selective and reversible inhibitor of monoamine oxidase-B (MAO-B) and also blocks sodium channels and N-type calcium channels. These effects of SAFM help reduce the breakdown of dopamine and inhibit the release of glutamate. NW-1689 has a similar chemical structure to SAFM and has some similar pharmacological effects as SAFM, and can be used in Parkinson's disease research.
    NW-1689